Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction

PURPOSE: Paclitaxel-based chemotherapy continues to be an integral component of breast cancer treatment. Prolonged use of paclitaxel may result in repeated doses of premedications that can have unwanted side effects. Infusion hypersensitivity reactions occurring beyond the second dose of paclitaxel...

Full description

Saved in:
Bibliographic Details
Published in:Support Care Cancer
Main Authors: Berger, Michael J., Vargo, Craig, Vincent, Mary, Shaver, Katy, Phillips, Gary, Layman, Rachel, Macrae, Erin, Mrozek, Ewa, Ramaswamy, Bhuvaneswari, Wesolowski, Robert, Shapiro, Charles L., Lustberg, Maryam B.
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4804339/
https://ncbi.nlm.nih.gov/pubmed/25519756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-014-2556-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items